COMPARATIVE EVALUATION OF SEVOFLURANE AND ISOFLURANE IN FAST TRACK ANAESTHESIA FOR VALVULAR CARDIAC SURGERY: A RANDOMIZED STUDY

Authors

  • DEEPAK KUMAR MEENA Department of Anaesthesiology, RVRS Government Medical College, Bhilwara, Rajasthan, India
  • PRADEEP CHARAN Department of Anaesthesiology, SMS Medical College, Jaipur, Rajasthan, India
  • ASHA SHARMA Department of Anaesthesiology, RVRS Government Medical College, Bhilwara, Rajasthan, India

DOI:

https://doi.org/10.22159/ijcpr.2024v16i2.4023

Keywords:

Fast track anaesthesia, Valvular cardiac surgery, Volatile anesthetic agents, Ischemic preconditioning

Abstract

Objective: Contemporary valvular cardiac surgery has evolved with the adoption of expedited postoperative recovery, known as fast-tracking. This paradigm shift results from advancements in anaesthetic agents, surgical techniques, and myocardial protection strategies. Fast-track anaesthesia aims to reduce intensive care unit (ICU) stays and overall hospital length of stay (LOS), optimizing resource utilization. Cardioprotective properties of volatile anaesthetic agents, especially in mitigating ischemic myocardial damage, have garnered attention.

Methods: A hospital-based, randomized, comparative study was conducted at the Department of Anaesthesiology, S. M. S Medical College, Jaipur. 70 undergoing valvular heart surgery under general anaesthesia, were randomly assigned to two groups: Group A (Sevoflurane) and Group B (Isoflurane). Inclusion criteria encompassed ASA grade II to IV patients aged 20 to 50 y, with a body weight of 30-65 kg, and willingness to provide written consent. Anaesthesia induction and maintenance involved the administration of Sevoflurane or Isoflurane based on group allocation. Hemodynamic parameters were recorded at various surgical stages.

Results: Heart rate, systolic blood pressure, and cardiac output were statistically insignificant between groups at different surgical stages (p>0.05). Intraoperative variables demonstrated no significant differences, except for a transient decrease in systolic blood pressure post-induction in both groups.

Conclusion: The study underscores the comparable efficacy of Sevoflurane and Isoflurane in valvular cardiac surgery, supported by similar hemodynamic profiles. Understanding the nuances of volatile anaesthetic agents is crucial for their optimal clinical application, considering challenges like beta-blocker usage and perioperative hyperglycemia.

Downloads

Download data is not yet available.

References

Belhomme D, Peynet J, Louzy M. Isoflurane preconditioning protects the myocardium against ischemic injury. Anesthesiology. 1999;91(1):15-24.

Lucchinetti E, Ambrosio S, Aguirre J, Herrmann P, Harter L, Keel M. Sevoflurane inhalation at sedative concentrations provides endothelial protection against ischemia-reperfusion injury in humans. Anesthesiology. 2007;106(2):262-8. doi: 10.1097/00000542-200702000-00013, PMID 17264719.

Zaugg M, Lucchinetti E, Spahn DR, Pasch T, Schaub MC. Volatile anesthetics mimic cardiac preconditioning by priming the activation of mitochondrial K(ATP) channels via multiple signaling pathways. Anesthesiology. 2002;97(1):4-14. doi: 10.1097/00000542-200207000-00003, PMID 12131097.

Kersten JR, Schmeling TJ, Pagel PS, Gross GJ, Warltier DC. Isoflurane mimics ischemic preconditioning via activation of K(ATP) channels: reduction of myocardial infarct size with an acute memory phase. Anesthesiology. 1997;87(2):361-70. doi: 10.1097/00000542-199708000-00024, PMID 9286901.

De Hert SG, Van der Linden PJ, Cromheecke S, Meeus R, Nelis A, Van Reeth V. Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration. Anesthesiology. 2004;101(2):299-310. doi: 10.1097/00000542-200408000-00009, PMID 15277911.

Gendron L, Pintar JE, Chavkin C. Essential role of mu opioid receptor in the regulation of delta opioid receptor-mediated antihyperalgesia. Neuroscience. 2007;150(4):807-17. doi: 10.1016/j.neuroscience.2007.09.060, PMID 17997230.

Julier K, da Silva R, Garcia C, Bestmann L, Frascarolo P, Zollinger A. Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: a double-blinded, placebo-controlled, multicenter study. Anesthesiology. 2003;98(6):1315-27. doi: 10.1097/00000542-200306000-00004, PMID 12766638.

De Hert SG, Turani F, Mathur S. Contemporary European practices of perioperative goal-directed fluid therapy and postoperative outcome: European Perioperative Clinical Outcome (EPCO) definitions: a multicenter, multinational, consensus-based study. J Am Soc Anesthesiol. 2014;120(3):615-22.

Landoni G, Lomivorotov VV, Nigro Neto C, Monaco F, Pasyuga VV, Bradic N. Volatile anesthetics versus total intravenous anesthesia for cardiac surgery. N Engl J Med. 2019;380(13):1214-25. doi: 10.1056/NEJMoa1816476, PMID 30888743.

Myles PS, Bellomo R, Corcoran T, Forbes A, Peyton P, Story D. Restrictive versus liberal fluid therapy for major abdominal surgery. N Engl J Med. 2018;378(24):2263-74. doi: 10.1056/NEJMoa1801601, PMID 29742967.

Kottenberg E, Thielmann M, Bergmann L, Heine T, Jakob H, Heusch G. Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol-a clinical trial. Acta Anaesthesiol Scand. 2012;56(1):30-8. doi: 10.1111/j.1399-6576.2011.02585.x, PMID 22103808.

Hausenloy DJ, Candilio L, Evans R, Ariti C, Jenkins DP, Kolvekar S. Remote ischemic preconditioning and outcomes of cardiac surgery. N Engl J Med. 2015;373(15):1408-17. doi: 10.1056/NEJMoa1413534, PMID 26436207.

Hausenloy DJ, Yellon DM. New directions for protecting the heart against ischemia-reperfusion injury: targeting the reperfusion injury salvage kinase (RISK)-pathway. Cardiovasc Res. 2004;61(3):448-60. doi: 10.1016/j.cardiores.2003.09.024, PMID 14962476.

Published

15-03-2024

How to Cite

MEENA, D. K., P. CHARAN, and A. SHARMA. “COMPARATIVE EVALUATION OF SEVOFLURANE AND ISOFLURANE IN FAST TRACK ANAESTHESIA FOR VALVULAR CARDIAC SURGERY: A RANDOMIZED STUDY”. International Journal of Current Pharmaceutical Research, vol. 16, no. 2, Mar. 2024, pp. 24-27, doi:10.22159/ijcpr.2024v16i2.4023.

Issue

Section

Original Article(s)